Risk Management

Cancelled: AAPOS 2020 in Austin, Texas, on March 25-29, 2020

March 25, 2020 – March 30, 2020 all-day
Fairmont Austin
101 Red River St
Austin, TX 78701
Contact AAPOS
Cancelled: AAPOS 2020 in Austin, Texas, on March 25-29, 2020 @ Fairmont Austin | Austin | Texas | United States

The live AAPOS 2020 is cancelled due to the issues surrounding the COVID-19 virus worldwide.  A “Virtual Meeting” is being organized and will be offered to members soon.


Join us for the 2020 meeting of the American Association for Pediatric Ophthalmology & Strabismus (AAPOS) on March 25-29, 2020 in Austin, Texas.  The OMIC session is on Thursday, March 26, 2020. Be sure stop by the OMIC booth at the event with any questions you have, and receive a free quote.

Date: Wednesday, March 25, 2020

Location: Fairmont Austin, Austin, Texas

Time: 4:00 p.m. to 5:00 p.m.

Topic: Recent Pediatric Ophthalmology & Strabismus Lawsuits

Speakers: Christie L. Morse, MD, OMIC Committee Member and Anne M. Menke, RN, PhD, OMIC Patient Safety Manager

The AAPOS website updates information regularly: go to http://www.aapos.org/

OMIC insureds who are also current AAPOS members and who attend this course will earn a 10%  premium discount!  Be sure to sign in while in the presentation room to ensure your OMIC discount.

For Your Administrators:
On Saturday, March 28, Anne Menke will present a session on a risk management topic to be announced soon.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Comments are closed.

Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.